PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 10846248

Photodermatology: progress, problems and prospects.

F P Gasparro
View original source ↗Export metadata ↓

Abstract

Photodermatology is a sub-specialty of photobiology. As such it includes all aspects of photobiology related to the skin ranging from sun exposure and its consequences (both short term and long term) to the therapeutic effects derived from exposure to natural or artificial radiation. In this review the terms photodermatology and photomedicine are used in a somewhat interchangeable fashion, although the former is really a portion of the latter. Four international journals are the primary sources for information - Photochemistry & Photobiology; Journal of Photochemistry & Photobiology (pt B); Photodermatology, Photomedicine & Photoimmunology; Journal of Investigative Dermatology. This review is structured so as to report on recent progress, existing problem areas and prospects for advances in the near future.

Explore related subjects

DermatologyHumansPhotobiologyPhotochemotherapyPhotopheresisPhotosensitizing AgentsSkin DiseasesSunscreening AgentsUltraviolet RaysJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

F P Gasparro. 2000. Photodermatology: progress, problems and prospects.. https://pubmed.ncbi.nlm.nih.gov/10846248/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2002

Clinical testing of a photoacoustic probe for port wine stain depth determination.

BACKGROUND AND OBJECTIVE: Successful laser treatment of port wine stain (PWS) birthmarks requires knowledge of lesion geometry. Laser parameters, such as pulse duration, wavelength, and radiant exposure, and other treatment parameters, such as cryogen spurt duration, need to be optimized according to epidermal melanin content and lesion depth. We designed, constructed, and clinically tested a photoacoustic probe for PWS depth determination. STUDY DESIGN/MATERIALS AND METHODS: Energy from a frequency-doubled, Nd:YAG laser (lambda=532 nm, tau(p)=4 nanoseconds) was coupled into two 1,500 mum optical fibers fitted into an acrylic handpiece containing a piezoelectric acoustic detector. Laser light induced photoacoustic waves in tissue phantoms and a patient's PWS. The photoacoustic propagation time was used to calculate the depth of the embedded absorbers and PWS lesion. RESULTS: Calculated chromophore depths in tissue phantoms were within 10% of the actual depths of the phantoms. PWS depths were calculated as the sum of the epidermal thickness, determined by optical coherence tomography (OCT), and the epidermal-to-PWS thickness, determined photoacoustically. PWS depths were all in the range of 310-570 microm. The experimentally determined PWS depths were within 20% of those measured by optical Doppler tomography (ODT). CONCLUSIONS: PWS lesion depth can be determined by a photoacoustic method that utilizes acoustic propagation time.

Dermatology↗
PubMed2002

Recent advances in dermatology.

Novel therapies for dermatologic diseases are now widely available to the clinician. The topical immune modulators tacrolimus and pimecrolimus are likely to change the way in which inflammatory dermatoses are treated. Antiviral and antitumor effects of imiquimod, another immune-response modifier, are being studied to determine the ways in which it may affect the treatment of cutaneous viral infections and skin cancers. New topical treatments for onychomycosis and the current lack of effective treatments for nondermatophyte onychomycosis indicate the need for more effective treatment for this common disease. Exciting developments in skin substitutes and growth factors for acute and chronic wound care hold much promise for the future.

Dermatology↗
PubMed2002

Pharmacogenetics in clinical dermatology.

Systemic therapies are increasingly used in the management of common skin diseases, and drug toxicity and relative lack of efficacy remain significant problems. In addition, we are unable to predict life-threatening adverse reactions such as toxic epidermal necrolysis. Pharmacogenetics, the study of how genetic differences influence the variability of individual patient responses to drugs, aims to distinguish responders from non-responders and predict those in whom toxicity is likely. Successful application of pharmacogenetics should lead to rationalized drug therapy. Recent advances in molecular genetic techniques such as high-throughput genotyping and microarrays have the potential to provide a practicable and economical approach to future pharmacogenetic testing. Pharmacogenetics will change not only the way drugs are selected but will also impact on clinical trial design and the costs of healthcare delivery.

Dermatology↗